Analysis of more than 370,000 Medicare enrollees over 65 diagnosed with COVID-19 showed that the use of ACEI, ARB, statins, warfarin, direct factor Xa inhibitors and P2Y12 inhibitors was associated with a reduction in the risk of catching COVID-19 and developing severe disease. The gene discussed is P2RY12; the disease is COVID-19.